Carboplatin was initially discovered and researched in March 1994 by the London Institute of Cancer Research, it gained Food and Drug Administration. In 2004 a generic version of the drug became available.
Carboplatin is a modification of Cisplatin drug but with less severe side effects than most chemotherapy medications. It is sometimes used for mesothelioma treatment and is commonly administered for treating lung, ovarian, neck and head cancers.
This medicine binds with DNA and makes the cells function abnormally until in the end, they die. It is an out-patient medication carried out in a hospital or cancer treatment center. Some patients might need to stay in a hospital overnight if the doctor deems necessary for more frequent sessions or a combination with other drugs. Continue reading ‘Carboplatin Treatment for Mesothelioma’ »